These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 17112877

  • 21. Association between cyclosporine concentrations at 2 hours post-dose and clinical outcomes in de novo lung transplant recipients.
    Akhlaghi F, Gonzalez L, Trull AK.
    J Heart Lung Transplant; 2005 Dec; 24(12):2120-8. PubMed ID: 16364860
    [Abstract] [Full Text] [Related]

  • 22. Comparison of pharmacokinetics of Neoral and Sandimmune in stable pediatric liver transplant recipients.
    van Mourik ID, Thomson M, Kelly DA.
    Liver Transpl Surg; 1999 Mar; 5(2):107-11. PubMed ID: 10071349
    [Abstract] [Full Text] [Related]

  • 23. Cyclosporine C2 monitoring is superior to C0 in predicting acute cellular rejection in heart transplant recipients in Taiwan.
    Chou NK, Chen RJ, Ko WJ, Lin HL, Yu SY, Chen YS, Hsu RB, Lee CM, Lin FY, Wang SS.
    Transplant Proc; 2004 Oct; 36(8):2393-5. PubMed ID: 15561260
    [Abstract] [Full Text] [Related]

  • 24. Switching monitoring of emulsified cyclosporine from trough level to 2-hour level in stable liver transplant patients.
    Langers P, Cremers SC, den Hartigh J, Veenendaal RA, ten Hove WR, Ringers J, Lamers CB, van Hoek B.
    Liver Transpl; 2004 Feb; 10(2):183-9. PubMed ID: 14762854
    [Abstract] [Full Text] [Related]

  • 25. Effect of diltiazem on the pharmacokinetics of microemulsion cyclosporine A in renal transplantation.
    Bunnag S, Vareesangthip K, Ong-ajyooth L.
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S228-34. PubMed ID: 17044476
    [Abstract] [Full Text] [Related]

  • 26. Target range maximum of cyclosporine blood concentration two hours post dose in stable liver transplant patients.
    Li J, Dahmen U, Beckebaum S, Cicinnati V, Valentin-Gamazo C, Frilling A, Malago M, Broelsch CE.
    Eur J Med Res; 2006 Apr 28; 11(4):139-45. PubMed ID: 16720277
    [Abstract] [Full Text] [Related]

  • 27. Two-hour postdose concentration: a reliable marker for cyclosporine exposure in adolescents with stable renal transplants.
    John U, Ullrich S, Roskos M, Misselwitz J.
    Transplant Proc; 2005 Apr 28; 37(3):1608-11. PubMed ID: 15866686
    [Abstract] [Full Text] [Related]

  • 28. Therapeutic drug monitoring of tacrolimus in cardiac transplant recipients: a comparison with cyclosporine neoral.
    Wang CH, Ko WJ, Chou NK, Wang SS.
    Transplant Proc; 2004 Oct 28; 36(8):2386-7. PubMed ID: 15561257
    [Abstract] [Full Text] [Related]

  • 29. Analysis of liver function in renal transplant recipients undergoing C2-monitoring for cyclosporine.
    Hecking M, Kainz A, Schillinger M, Posch C, Birsan T, Rasoul-Rockenschaub S, Böhmig GA, Schmaldienst S, Watschinger B, Hörl WH, Mühlbacher F, Säemann MD.
    Transpl Int; 2008 Mar 28; 21(3):223-33. PubMed ID: 17903183
    [Abstract] [Full Text] [Related]

  • 30. A randomized, controlled trial of C0- Vs C2-guided therapeutic drug monitoring of cyclosporine in stable heart transplant patients.
    Mathias HC, Ozalp F, Will MB, Borland W, Payne C, Kerr M, Lockhart J, Murday AJ.
    J Heart Lung Transplant; 2005 Dec 28; 24(12):2137-43. PubMed ID: 16364862
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Advantages of C2 monitoring to avoid acute rejection in pediatric heart transplant recipients.
    Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Hübler M, Abd El Rahman MY, Miera O, Ewert P, Weng Y, Wei H, Krüdewagen B, Hetzer R, Berger F.
    J Heart Lung Transplant; 2006 Jun 28; 25(6):619-25. PubMed ID: 16730566
    [Abstract] [Full Text] [Related]

  • 33. Rationale for monitoring cyclosporine concentration at 2 hours after administration in infants posttransplantation.
    Furlan V, Lykavieris P, Maubert MA, Habes D, Debray D.
    Transplant Proc; 2009 Oct 28; 41(8):3333-4. PubMed ID: 19857744
    [Abstract] [Full Text] [Related]

  • 34. Long-term comparative results of C0 and C2 monitoring of CyA in renal transplanted patients.
    Paydaş S, Balal M, Sertdemir Y, Seyrek N, Karayaylali I.
    Ren Fail; 2005 Oct 28; 27(4):409-13. PubMed ID: 16060128
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Experience with conversion from Sandimmun to Neoral cyclosporine and the correlation of C2 levels with renal function.
    Konstadinidou I, Boletis JN.
    Transplant Proc; 2004 Mar 28; 36(2 Suppl):163S-166S. PubMed ID: 15041329
    [Abstract] [Full Text] [Related]

  • 37. C2 and C0 values for monitoring cyclosporine therapy in stable heart transplant recipients.
    Diciolla F, Scolletta S, Berti L, Maccherini M, Federici D, Bernazzali S, Lisi G, Chiavarelli M.
    Transplant Proc; 2005 Mar 28; 37(2):1355-9. PubMed ID: 15848719
    [Abstract] [Full Text] [Related]

  • 38. Abbreviated AUC monitoring of cyclosporine more adequately identified patients at risk for acute rejection during induction of immunosuppressive therapy after kidney transplantation than recommended C2 concentration values.
    Troncoso P, Ortiz AM, Jara A, Vilches S.
    Transplant Proc; 2009 Mar 28; 41(1):127-30. PubMed ID: 19249495
    [Abstract] [Full Text] [Related]

  • 39. Clinical outcomes and C2 cyclosporin monitoring in maintenance renal transplant recipients: 1 year follow-up study.
    Marcén R, Villafruela JJ, Pascual J, Teruel JL, Ocaña J, Tenorio MT, Burgos FJ, Ortuño J.
    Nephrol Dial Transplant; 2005 Apr 28; 20(4):803-10. PubMed ID: 15687111
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.